These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 2967076
1. Inhibition of thymidylate synthase in intact L1210 cells by ara-C, daunomycin, hydroxyurea and 3,4-dihydroxybenzylamine. FitzGerald GB, Ratliff J, Wick MM. Anticancer Drug Des; 1987 Apr; 1(4):281-9. PubMed ID: 2967076 [Abstract] [Full Text] [Related]
2. Comparison of the inhibitory effects of hydroxyurea, 5-fluorodeoxyuridine, 3,4-dihydroxybenzylamine, and methotrexate on human squamous cell carcinoma. FitzGerald GB, Wick MM. J Invest Dermatol; 1987 Jan; 88(1):66-70. PubMed ID: 2947954 [Abstract] [Full Text] [Related]
3. Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes. Fitzgerald GB, Wick MM. Biochem Pharmacol; 1986 Jan 15; 35(2):271-5. PubMed ID: 3510622 [Abstract] [Full Text] [Related]
4. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells. Walsh CT, Craig RW, Agarwal RP. Cancer Res; 1980 Sep 15; 40(9):3286-92. PubMed ID: 7427943 [Abstract] [Full Text] [Related]
5. The effects of inhibitors of DNA biosynthesis on the cytotoxicity of 6-thioguanine. Lee SH, Sartorelli AC. Cancer Biochem Biophys; 1981 Sep 15; 5(3):189-94. PubMed ID: 6455192 [Abstract] [Full Text] [Related]
6. Role of methylenetetrahydrofolate depletion in methotrexate-mediated intracellular thymidylate synthesis inhibition in cultured L1210 cells. Bunni M, Doig MT, Donato H, Kesavan V, Priest DG. Cancer Res; 1988 Jun 15; 48(12):3398-404. PubMed ID: 3370638 [Abstract] [Full Text] [Related]
7. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro. Yalowich JC, Kalman TI. Biochem Pharmacol; 1985 Jul 01; 34(13):2319-24. PubMed ID: 3160352 [Abstract] [Full Text] [Related]
8. Morphologic differences in leukemic cells (L1210) exposed to 1-beta-D-arabinofuranosylcytosine and daunorubicin. Iwasaki H, Aoyama H, Ueda T, Uchida M, Nakamura T. Anticancer Res; 1992 Jul 01; 12(3):941-7. PubMed ID: 1622152 [Abstract] [Full Text] [Related]
9. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures. Roberts D, Franklin P, Odom G, Peck C, Chwang TL. Mol Pharmacol; 1982 Nov 01; 22(3):760-5. PubMed ID: 6218391 [Abstract] [Full Text] [Related]
10. Regulation of thymidylate synthetase in mouse leukemia cells (L1210). Rode W, Scanlon KJ, Moroson BA, Bertino JR. J Biol Chem; 1980 Feb 25; 255(4):1305-11. PubMed ID: 6965493 [Abstract] [Full Text] [Related]
11. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine. Okabe-Kado J, Hayashi M, Honma Y, Hozumi M. Cancer Res; 1986 Mar 25; 46(3):1239-43. PubMed ID: 3455882 [Abstract] [Full Text] [Related]
12. bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C, Hickman JA. Cancer Res; 1993 Jul 15; 53(14):3321-6. PubMed ID: 8324744 [Abstract] [Full Text] [Related]
13. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells. Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA. Cancer Res; 1984 Dec 15; 44(12 Pt 1):5583-93. PubMed ID: 6208999 [Abstract] [Full Text] [Related]
14. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity. Rauscher F, Cadman E. Cancer Res; 1983 Jun 15; 43(6):2688-93. PubMed ID: 6189585 [Abstract] [Full Text] [Related]
15. Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice. Rauko P, Bauer W, Horvath Z, Höchtl T, Saiko P, Karl D, Schott H, Fritzer-Szekeres M, Novotny L, Szekeres T. Anticancer Res; 2003 Jun 15; 23(5A):3841-6. PubMed ID: 14666686 [Abstract] [Full Text] [Related]
16. Inhibition of ribonucleotide reductase by a new class of isoindole derivatives: drug synergism with cytarabine (Ara-C) and induction of cellular apoptosis. Nandy P, Lien EJ, Avramis VI. Anticancer Res; 1999 Jun 15; 19(3A):1625-33. PubMed ID: 10470093 [Abstract] [Full Text] [Related]
17. Interconversion of tetrahydrofolate cofactors to dihydrofolate induced by trimetrexate after suppression of thymidylate synthase by fluorodeoxyuridine in L1210 leukemia cells. Seither RL, Rape TJ, Goldman ID. Biochem Pharmacol; 1992 Jun 23; 43(12):2647-54. PubMed ID: 1385949 [Abstract] [Full Text] [Related]
18. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Gibbs DD, Theti DS, Wood N, Green M, Raynaud F, Valenti M, Forster MD, Mitchell F, Bavetsias V, Henderson E, Jackman AL. Cancer Res; 2005 Dec 15; 65(24):11721-8. PubMed ID: 16357184 [Abstract] [Full Text] [Related]
19. Allosteric interaction of components of the replitase complex is responsible for enzyme cross-inhibition. Plucinski TM, Fager RS, Reddy GP. Mol Pharmacol; 1990 Jul 15; 38(1):114-20. PubMed ID: 1695315 [Abstract] [Full Text] [Related]
20. Thymidylate synthetase as target enzyme for the inhibitory activity of 5-substituted 2'-deoxyuridines on mouse leukemia L1210 cell growth. De Clercq E, Balzarini J, Torrence PF, Mertes MP, Schmidt CL, Shugar D, Barr PJ, Jones AS, Verhelst G, Walker RT. Mol Pharmacol; 1981 Mar 15; 19(2):321-30. PubMed ID: 7231392 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]